Research - , California, United States
The mission of BlueJay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. BlueJay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
Outlook
Eventbrite
Google Tag Manager
Google Font API
Microsoft Office 365
GoDaddy Hosting